Results 1 to 10 of about 1,370,058 (187)

Inflammation and Perioperative Cardiovascular Events [PDF]

Cells
Surgery and anesthesia induce a stress response that provokes increased sympathetic stimulation, secretion of cortisol, hypercoagulability, and systemic inflammatory response.
Peter Poredos, Radko Komadina
doaj   +2 more sources

Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Although there is research on the impact of social determinants of health (SDOHs) on cardiovascular health, most existing evidence is based on individual SDOH components. We evaluated the impact of cumulative SDOH burden on cardiovascular risk
Isaac Acquah, Kobina Hagan, Zulqarnain Javed, Mohamad B. Taha, Javier Valero‐Elizondo, Nwabunie Nwana, Tamer Yahya, Garima Sharma, Martha Gulati, Aziz Hammoud, Michael D. Shapiro, Ron Blankstein, Michael J. Blaha, Miguel Cainzos‐Achirica, Khurram Nasir   +14 more
doaj   +3 more sources

Risk of Cardiovascular Events Using the SMART Polyvascular Disease Risk Score [PDF]

JACC: Advances
:: Background: Secondary Manifestations of Arterial Disease (SMART) risk score–based projection of risk for cardiovascular (CV) events can help devise risk mitigation strategies. Objectives: The objective of the study was to analyze the use of the SMART
Subhash Banerjee, MD, Anand Gupta, MBBS, MPH, Minseob Jeong, MD, David Fernandez Vazquez, MD, Shuaib Abdullah, MD, Bradley R. Grimsley, MD, Rohit J. Parmar, MD, Vishal Ahuja, PhD, Robert C. Stoler, MD, Ambarish Pandey, MD   +9 more
doaj   +2 more sources

Perindopril for improving cardiovascular events

Vascular Health and Risk Management, 2014
James J DiNicolantonio, James H O'Keefe Department of Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO, USAIn a recent review in Vascular Health and Risk Management Wang et al state that “In mainly placebo ...
DiNicolantonio JJ, O’Keefe JH
doaj   +5 more sources

Testosterone replacement therapy and cardiovascular events

Türk Kardiyoloji Derneği Arşivi, 2017
A low testosterone level and hypogonadism are associated with cardiovascular disease. Aging, chronic health problems, and obesity are all associated with a low testosterone level as well as the presence and severity of cardiovascular disease ...
Alp Burak Çatakoğlu, Muammer Kendirci
doaj   +3 more sources

Cardiovascular Events After Intracerebral Hemorrhage

Stroke, 2022
Cardiovascular events after primary intracerebral hemorrhage (ICH) have emerged as a leading cause of poor functional outcomes and mortality during the long-term recovery after an ICH. These events encompass arterial ischemic events such as ischemic stroke and myocardial infarction, arterial hemorrhagic events that include recurrent ICH, and venous ...
Li, L, Murthy, SB
openaire   +2 more sources

Childhood cardiovascular risk factors and adult cardiovascular events

Yearbook of Paediatric Endocrinology, 2022
Childhood cardiovascular risk factors predict subclinical adult cardiovascular disease, but links to clinical events are unclear.In a prospective cohort study involving participants in the International Childhood Cardiovascular Cohort (i3C) Consortium, we evaluated whether childhood risk factors (at the ages of 3 to 19 years) were associated with ...
Jacobs, DR, Woo, JG, Sinaiko, AR, Daniels, SR, Ikonen, J, Juonala, M, Kartiosuo, N, Lehtimäki, T, Magnussen, CG, Viikari, JSA, Zhang, N, Bazzano, LA, Burns, TL, Prineas, RJ, Steinberger, J, Urbina, EM, Venn, AJ, Raitakari, OT, Dwyer, T   +18 more
openaire   +6 more sources

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The sodium‐glucose cotransporter 2 inhibitor canagliflozin reduced the risk of first cardiovascular composite events in the CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) trial.
Jing‐Wei Li, Clare Arnott, Hiddo J. L. Heerspink, Qiang Li MBiostat, Christopher P. Cannon, David C. Wheeler, David M. Charytan, Jennifer Barraclough, Gemma A. Figtree, Rajiv Agarwal, George Bakris, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey, Vlado Perkovic, Bruce Neal, Meg J. Jardine   +20 more
doaj   +1 more source

Comparison of incidence/occurrence of cardiovascular events between ponatinib vs bosutinib among patients with at least one prior line of tyrosine kinase inhibitors in chronic myeloid leukemia in a community setting in the United States

Cancer Treatment and Research Communications, 2021
Introduction: In this real-world study, the incidence of cardiovascular events (CV) including major adverse cardiac events (MACE), arterial occlusive events (AOE), and venous occlusive events (VOE) was evaluated in chronic myeloid leukemia (CML) patients
Moshe Levy, Lin Xie, Yuexi Wang, Frank Neumann, Shouryadeep Srivastava, Daniel Naranjo, Jing Xu, Qisu Zhang, Mehul Dalal   +8 more
doaj   +1 more source

Depression and Screening Cardiovascular Events [PDF]

Journal of General Internal Medicine, 2008
To the Editor: —Peripheral arterial disease (PAD) remains an under-treated disease1, and information about risk factors and prognosis is poorly disseminated in the population2. Nevertheless, PAD and coronary artery disease (CAD) patients share the same risk factors, and risks of future cardiovascular events in PAD patients are comparable with those in ...
Smolderen, K.G.E., Aquarius, A.E.A.M., Denollet, J.   +2 more
openaire   +2 more sources